Agnès Vignery, osteoporosis researcher, named Yale-Pfizer Visiting Faculty

November 01, 2005

New Haven, Conn. --Agnès Vignery, associate professor of orthopaedics and rehabilitation, and cell biology has been named Yale-Pfizer Global Discovery Visiting Professor for 2005.

At Pfizer's Groton Laboratories, Vignery, whose research focuses on the developmental and reconstructive processes of bone, will serve as a consultant to David Ke in the bone biology section, and John Cheng in the biomarkers group. She will be conducting collaborative research and gaining practical knowledge of the drug discovery and development process through interactions with the project teams.

The program offers a 12-week position for one outstanding Yale faculty member to consult and do research on site at Pfizer Global Research and Development in Groton / New London. While it strengthens Yale-Pfizer alliances, it provides Yale faculty with new collaborations and a better understanding of the pharmaceutical industry.

"We are pleased that the Pfizer Visiting Professor Program is proving to be such a successful partnership," said Merle Waxman, associate dean and director of the Office for Women in Medicine at Yale School of Medicine. "Our scientists gain great first-hand experience in the challenges of the pharmaceutical industry and then have the unique opportunity to bring these insights back to their students and fellows."

The novel visiting professorship, now in its second year, was developed and sponsored by the Discovery Laboratories at Pfizer Global Research and Development, the Women's Leadership Network at Pfizer and the Office for Women in Medicine at Yale.

"This is an honor that has given me the opportunity to work with a premier pharmaceutical company on research that is not only important to me, but important to improving health care in the United States," said Vignery.

Vignery's lab recently developed a new technology to induce bone formation locally for the prevention of fractures and the repair of non-union fractures. The technology is being refined in rodents, anticipating its rapid translation to humans.

"One vision for the program is to enhance the scientific understanding between Pfizer and Yale, and, more broadly, between industry and academia. We have already seen how beneficial these interactions can be," said Karen Houseknecht, president of the Women's Leadership Network at Pfizer. "We look forward to this program expanding the vista of career choices for academic scientists."
-end-


Yale University

Related Cell Biology Articles from Brightsurf:

Deep learning on cell signaling networks establishes AI for single-cell biology
Researchers at CeMM have developed knowledge-primed neural networks (KPNNs), a new method that combines the power of deep learning with the interpretability of biological network models.

RNA biology provides the key to cell identity and health
Two papers in Genome Research by the FANTOM Consortium have provided new insights into the core regulatory networks governing cell types in different vertebrate species, and the role of RNA as regulators of cell function and identity.

Cell biology: Your number's up!
mRNAs program the synthesis of proteins in cells, and their functional lifetimes are dynamically regulated.

Cell biology -- maintaining mitochondrial resilience
Mitochondria cannot autonomously cope with stress and must instead call on the cell for help.

Cell biology: All in a flash!
Scientists of Ludwig-Maximilians-Universitaet (LMU) in Munich have developed a tool to eliminate essential proteins from cells with a flash of light.

A biology boost
Assistance during the first years of a biology major leads to higher retention of first-generation students.

Cell-free synthetic biology comes of age
In a review paper published in Nature Reviews Genetics, Professor Michael Jewett explores how cell-free gene expression stands to help the field of synthetic biology dramatically impact society, from the environment to medicine to education.

Scientists develop electrochemical platform for cell-free synthetic biology
Scientists at the University of Toronto (U of T) and Arizona State University (ASU) have developed the first direct gene circuit to electrode interface by combining cell-free synthetic biology with state-of-the-art nanostructured electrodes.

In a first for cell biology, scientists observe ribosome assembly in real time
A team of scientists from Scripps Research and Stanford University has recorded in real time a key step in the assembly of ribosomes -- the complex and evolutionarily ancient 'molecular machines' that make proteins in cells and are essential for all life forms.

Cell biology: Endocannabinoid system may be involved in human testis physiology
The endocannabinoid system (ECS) may be directly involved in the regulation of the physiology of the human testis, including the development of sperm cells, according to a study in tissue samples from 15 patients published in Scientific Reports.

Read More: Cell Biology News and Cell Biology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.